Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity

Andrzej T. Slominski, Zorica Janjetovic, Brian E. Fuller et al. · 2010

Read Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity by Andrzej T. Slominski, Zorica Janjetovic, Brian E. Fuller et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009907.txt.

Description

Vitamin D compounds can slow leukemia cells, but many also raise blood calcium dangerously. Andrzej Slominski and colleagues tested safer products made from vitamin D building blocks. Their study appeared in PLOS ONE in 2010. Calcemic activity means raising calcium levels in the blood.

The products came from vitamin D3 or from 7-dehydrocholesterol, processed by the enzyme cytochrome P450scc. They showed anti-leukemia effects in the tests. Crucially, they had low or absent calcemic activity, so they did not spike calcium. Safer vitamin D relatives could widen treatment options. Low calcium risk is the key gain here.

Catalog record

CREATORAndrzej T. Slominski, Zorica Janjetovic, Brian E. Fuller et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009907

Browse the full library · About the Tower of Babel